Glenmark Pharma Gains 1.5% on US FDA Nod for Olopatadine
Shares of Glenmark Pharmaceuticals Ltd surged 1.5% to touch a day’s high of Rs 1,509 on 21st March after the firm announced that its subsidiary,...
Tag : Glenmark Pharma
Glenmark Denies Allegations, Settles Lawsuits for $7 Million; Shares Jump 3.5%
Shares of Glenmark Pharmaceuticals Ltd surged 3.5% to hit a day’s high of Rs 1,354.85 on 24th February, after the company denied allegations in multiple...
Eris Shares Fall 4% in 2-Days After Buying 9 Derma Brands from Dr Reddy’s
Shares of Eris Lifesciences fell 2% in intraday trade on Friday, touching a two-year low of Rs 570. The stock fell 4% two days after...
Glenmark Pharma Shares Up 5% After December Quarter Earnings
Shares of Glenmark Pharma surged more than 5% to a high of Rs 421 in an otherwise subdued market after the drugmaker reported stable earnings...
Markets Snap 4-Day Losing Streak; Sensex, Nifty Rise as Autos, Banks Rebound
Indian stocks snapped a four-day losing streak on Monday. Top indices, S&P BSE Sensex and NSE Nifty50 extended gains after a cautious start. The Sensex...
Glenmark to Conduct Phase 1 Trials of Its Molecule on Cancer Patients
Glenmark Pharma said it had received approval from the Drug Controller General of India (DCGI) to conduct phase 1 clinical trials of its molecule, GRC...
Glenmark Pharmaceuticals Receives US FDA Approval
The US health regulator, US FDA, has approved Glenmark Pharmaceuticals Ltd’s Teriflunomide tablets, which used to treat multiple sclerosis into the US market. The approved...
Glenmark Pharma Profit For The June Quarter At Rs. 232.99 Crores
One of India’s largest pharmaceutical company, Glenmark Pharma, reported their net consolidated profit for the June-end quarter of the current fiscal year at Rs. 232.99...
Glenmark Pharma receives USFDA nod for Colesevelam Hydrochloride
Glenmark Pharma has received final approval for Colesevelam Hydrochloride, from USFDA. Colesevelam Hydrochloride is a generic version of Welchol 1 of Daiichi Sankyo Inc and the...
Glenmark Pharma signs agreement with Seqirus
Glenmark Pharma’s subsidiary Glenmark Specialty, has entered into an exclusive licensing agreement with Australia’s Seqirus to commercialize its nasal spray, Ryaltris in Australia and New...